-
Oct 27, 2026Prisys Contributes To Nature Neuroscience Study On Psychedelic Pharmacology A...Explore Prisys’s contribution to a Nature Neuroscience study of 5-HT2A receptor signaling, including 3D behavioral analysis and functional testing in cynomolgus monkeys. -
Nov 10, 2026AI Scratching Behavior Analysis in NHP Pruritus Models | PrisysDiscover how AI-powered 3D behavioral analysis quantifies scratching in cynomolgus macaque pruritus models to support preclinical anti-itch drug evaluation. -
Nov 05, 2026AI-Powered 3D Behavioral Phenotyping in Non-Human Primates: From Video To Qua...Explore how AI-powered 3D behavioral phenotyping quantifies NHP movement, posture, gait and behavior to support translational pharmacology and preclinical drug development. -
![Imaging Dopamine D2/D3 Receptors in Non-Human Primates With [18F]Fallypride](/uploads/39406/page/2026110313202838af1.jpg)
Nov 03, 2026Imaging Dopamine D2/D3 Receptors in Non-Human Primates With [18F]FallyprideExplore how [18F]Fallypride PET imaging in cynomolgus monkeys evaluates dopamine D2/D3 receptor binding, pharmacological displacement, and target engagement. -
Oct 30, 2026Biomarkers in Translational Medicine: Connecting Preclinical Pharmacology Wit...Learn how PK/PD biomarkers, target engagement and cross-species studies connect preclinical pharmacology with clinical dose selection and patient stratification. -
Oct 22, 2026Imaging VMAT2 in A Non-human Primate Model Of Parkinson's DiseaseSee how [18F]AV-133 PET/CT and PET/MRI were used to assess dopaminergic integrity in a unilateral striatal lesion model of Parkinson's disease. -
Oct 20, 2026Evaluating Motor Function in Preclinical Parkinson's Disease StudiesLearn how to assess motor function in preclinical Parkinson’s disease studies, improve observer consistency, control baseline differences, and interpret drug effects. -
Oct 16, 2026NHP AV Shunt Thrombosis: Flow, Thrombus & BleedingLearn how flow, thrombus burden and hemostasis endpoints can be integrated in NHP AV shunt thrombosis studies—and where interpretation has limits. -
Oct 13, 2026Longitudinal Tau PET in A Rhesus Macaque Model: An NHP Case StudySee how serial [18F]APN-1607 PET was used to follow tau-associated signal in a rhesus AAV-2xTau model at 3 and 6 months. -
Oct 10, 2026NHP Liver Fibrosis Imaging: MRI-PDFF, MRE And BiopsyLearn what MRI-PDFF, MRE and liver biopsy measure in NHP fibrosis studies, how their endpoints differ, and what model-specific validation is needed. -
Oct 05, 2026Ac-225 Human Dose Projection From NHP ImagingHow NHP imaging can support Ac-225 human dose projection? Learn how serial PET or SPECT imaging in NHPs can support Ac-225 dosimetry, organ dose estimates, and first-in-human ac... -
Sep 14, 2026Webinar Recap: Molecular Imaging in NHP Models For Translational Drug Develop...Explore how molecular imaging in NHP models supports biodistribution, target engagement, PK/PD, dosimetry, and longitudinal translational drug development.
